<DOC>
	<DOC>NCT00169507</DOC>
	<brief_summary>Evaluate the immunological memory induced by 4 doses of GSK Biologicals' 11valent pneumococcal vaccine; study antibody persistence 30 months after the 4 dose vaccination with GSK Biologicals' 11-valent pneumococcal vaccine in Undeca-Pn-010 study.</brief_summary>
	<brief_title>Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23)</brief_title>
	<detailed_description>Primed group: 50 subjects who previously received 4 doses of GSK Biologicals' 11Pn-PD vaccine will receive 1 dose of Pneumo 23 Unprimed group (Control): 50 subjects who received GSK Biologicals' Havrixâ„¢ vaccine will receive 1 dose of Pneumo 23</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion criteria: Male or female who participated in UndecaPn010 study, were part of the blood subset and received 4 doses of GSK Biologicals' 11PnPD vaccine, or Havrix vaccine. Exclusion criteria: Use of any investigational or nonregistered drug or vaccine other than the study vaccine within 30 days preceeding the first dose of study vaccine, or planned use during the study period. Administration of any additional pneumococcal vaccine since study end of UndecaPn010 (347414/010)</criteria>
	<gender>All</gender>
	<minimum_age>31 Months</minimum_age>
	<maximum_age>57 Months</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>